NASDAQ: NXGL
NEXGEL, Inc.
Healthcare · Medical - Instruments & Supplies
After hours: $0.35(-7.87%) · as of 7:45 PM ET
Market Cap
$3.22M
52w High
$2.89
52w Low
$0.33
P/E
-0.96
Volume
170.42K
Outstanding Shares
8.48M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock fell 85.61% over the last year. Revenue grew 10.14% over the trailing twelve months. Operating margin moved from -33.83% to -31.37%. Free cash flow grew 58.92% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -31.37%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
1
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 11, 2026
Q3 FY26 · EPS est -$0.12 · Revenue est $4.32M
View